The tachykinin tale: Molecular recognition in a historical perspective

Journal of Molecular Recognition

Volumn 20, Issue 3, 2007, Pages 145-153

  Werge, Thomas ^a  

^a Sct Hans Hospital   (Denmark)

Author keywords

Antibody mimicry; Binding site; G protein coupled receptors; Message address model; Neuropeptide; Selectivity; Specificity; Structure activity relationship

Indexed keywords

TACHYKININ; TACHYKININ RECEPTOR;

ANIMAL; CHEMISTRY; HISTORY; HUMAN; PROTEIN CONFORMATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PROTEIN CONFORMATION; RECEPTORS, TACHYKININ; STRUCTURE-ACTIVITY RELATIONSHIP; TACHYKININS;

EID: 34447537725     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.822     Document Type: Review

References (54)

1. Amati V, Werge TM, Cattaneo A, Tramontano A. 1995. Identifying a putative common binding site shared by substance P receptor and an anti-substance P monoclonal antibody. Protein Eng. 8: 403-408.
2. Anastasi A, Erspamer V. 1962. Occurrence and some properties of eledoisin in extracts of posterior salivary glands of Eledone. Br. J. Pharmacol. Chemother. 19: 326-336.
3. Anastasi A, Erspamer V, Cei J. 1964. Isolation and amino acid sequence of physalaemin, the main active polypeptide of the skin of Physalaemus Fuscumaculatus. Arch. Biochem. Biophys. 108: 341-348.
4. Aramori I, Morikawa N, Zenkoh J, O'Donnell N, Iwami M, Kojo H, Notsu Y, Okuhara M, Ono S, Nakanishi S. 1994. Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors. Eur. J. Pharmacol. 269: 277-281.
5. Barr AJ, Watson SP. 1993. Non-peptide antagonists, CP-96, 345 and RP 67580,distinguish species variants in tachykinin NK1 receptors. Br. J. Pharmacol. 108: 223-227.
6. Boyd ND, Kage R, Dumas JJ, Krause JE, Leeman SE. 1996. The peptide binding site of the substance P (NK-1) receptor localized by a photoreactive analogue of substance P: presence of a disulfide bond. Proc. Natl. Acad. Sci. USA 93: 433-437.
7. Bremer AA, Leeman SE, Boyd ND. 2000. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor. FEBS Lett. 486: 43-48.
8. Bremer AA, Leeman SE, Boyd ND. 2001. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP. J. Biol. Chem. 276: 22857-22861.
9. Chang MM, Leeman SE. 1970. Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J. Biol. Chem. 245: 4784-4790.
10. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Roberto J, Poljak RJ. 1989. Conformations of immunoglobulin hypervariable regions. Nature 342: 877-883.
11. Ciucci A, Palma C, Riitano D, Manzini S, Werge TM. 1997. Gly166 in the NK1 receptor regulates tachykinin selectivity and receptor conformation. FEBS Lett. 416: 335-338.
12. Ciucci A, Palma C, Manzini S, Werge TM. 1998. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Br. J. Pharmacol. 125: 393-401.
13. Cuello AC, Galfre G, Milstein C. 1979. Detection of substance P in the central nervous system by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 76: 3532-3536.
14. Dores RM, Rubin DA, Quinn TW. 1996. Is it possible to construct phylogenetic trees using polypeptide hormone sequences? Gen. Comp Endocrinol. 103: 1-12.
15. Elling CE, Nielsen SM, Schwartz TW. 1995. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor. Nature 374: 74-77.
16. Erspamer V. 1949. Ricerche preliminari sulla moschatina. Experientia 5: 79.
17. Erspamer V. 1981. The tachykinin peptide family. Trends Neurosci. 4: 267-269.
18. Erspamer V, Anastasi A. 1962. Structure and pharmacological actions of eledoisin, the active endecapeptide of the posterior salivary glands of Eledone. Experientia 18: 58-59.
19. Fong TM, Huang RR, Strader CD. 1992. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 267: 25664-25667.
20. Gether U, Johansen TE, Snider RM, Lowe JA III, Nakanishi S, Schwartz TW. 1993. Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. Nature 362: 345-348.
21. Girault S, Sagan S, Bolbach G, Lavielle S, Chassaing G. 1996. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor. Eur. J. Biochem. 240: 215-222.
22. Hastrup H, Schwartz TW. 1996. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Lett. 399: 264-266.
23. Hein L, Kobilka BK. 1995. Adrenergic receptor signal transduction and regulation. Neuropharmacology 34: 357-366.
24. Henderson R, Schertler GF. 1990. The structure of bacteriorhodopsin and its relevance to the visual opsins and other seven-helix G-protein coupled receptors. Philos. Trans. R. Soc. Lond B Biol. Sci. 326: 379-389.
25. Holmgren S, Jensen J. 2001. Evolution of vertebrate neuropeptides. Brain Res. Bull. 55: 723-735.
26. Holmgren S, Fritsche R, Karila P, Gibbins I, Axelsson M, Franklin C, Grigg G, Nilsson S. 1994. Neuropeptides in the Australian lungfish Neoceratodus forsteri: effects in vivo and presence in autonomic nerves. Am. J. Physiol. 266: R1568-R1577.
27. Holst B, Elling CE, Schwartz TW. 2000. Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor. Mol. Pharmacol. 58: 263-270.
28. Hoyle CH. 1998. Neuropeptide families: evolutionary perspectives. Regul. Pept. 73: 1-33.
29. Huang RR, Cheung AH, Mazina KE, Strader CD, Fong TM. 1992. cDNA sequence and heterologous expression of the human neurokinin-3 receptor. Biochem. Biophys. Res. Commun. 184: 966-972.
30. Jensen CJ, Gerard NP, Schwartz TW, Gether U. 1994. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. Mol. Pharmacol. 45: 294-299.
31. Kagstrom J, Axelsson M, Jensen J, Farrell AP, Holmgren S. 1996. Vasoactivity and immunoreactivity of fish tachykinins in the vascular system of the spiny dogfish. Am. J. Physiol. 270: R585-R593.
32. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ. 1988. Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 240: 1310-1316.
33. Lazarus LH, Wilson WE, Gaudino G, Irons BJ, Guglietta A. 1985. Evolutionary relationship between nonmammalian and mammalian peptides. Peptides 6(Suppl 3): 295-307.
34. Lee CM, Iversen LL, Hanley MR, Sandberg BE. 1982. The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch. Pharmacol. 318: 281-287.
35. Li YM, Marnerakis M, Stimson ER, Maggio JE. 1995. Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists. J. Biol. Chem. 270: 1213-1220.
36. Mirzadegan T, Benko G, Filipek S, Palczewski K. 2003. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42: 2759-2767.
37. Nakanishi S. 1987. Substance P precursor and kininogen: their structures, gene organizations, and regulation. Physiol Rev. 67: 1117-1142.
38. Nakanishi S. 1991. Mammalian tachykinin receptors. Annu. Rev. Neurosci. 14: 123-136.
39. Piccioli P, Ruberti F, Biocca S, Di LA, Werge TM, Bradbury A, Cattaneo A. 1991. Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system. Proc. Natl. Acad. Sci. USA 88: 5611-5615.
40. Piccioli P, Di LA, Amann R, Schuligoi R, Surani MA, Donnerer J, Cattaneo A. 1995. Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron 15: 373-384.
41. Pradier L, Habert-Ortoli E, Emile L, Le GJ, Loquet I, Bock MD, Clot J, Mercken L, Fardin V, Garret C, Mayaux JF. 1995. Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists. Mol. Pharmacol. 47: 314-321.
42. Regan L. 1993. The design of metal-binding sites in proteins. Annu. Rev. Biophys. Biomol. Struct. 22: 257-287.
43. Riitano D, Werge TM, Costa T. 1997. A mutation changes ligand selectivity and transmembrane signaling preference of the neurokinin-1 receptor. J. Biol. Chem. 272: 7646-7655.
44. Schertler GF, Villa C, Henderson R. 1993. Projection structure of rhodopsin. Nature 362: 770-772.
45. Schiller PW. 1972. Study of adrenocorticotropic hormone conformation by evaluation of intramolecular resonance energy transfer in N-dansyllysine 21-ACTH-(1-24)-tetrakosipeptide. Proc. Natl. Acad. Sci. USA 69: 975-979.
46. Schwyzer R. 1977. ACTH: a short introductory review. Ann. NY Acad. Sci. 297: 3-26.
47. Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. 2002. The tachykinin peptide family. Pharmacol. Rev. 54: 285-322.
48. Soppa J. 1994. Two hypotheses - one answer. Sequence comparison does not support an evolutionary link between halobacterial retinal proteins including bacteriorhodopsin and eukaryotic G-protein-coupled receptors. FEBS Lett. 342: 7-11.
49. Takahashi K, Tanaka A, Hara M, Nakanishi S. 1992. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur. J. Biochem. 204: 1025-1033.
50. Taylor EW, Agarwal A. 1993. Sequence homology between bacteriorhodopsin and G-protein coupled receptors: exon shuffling or evolution by duplication? FEBS Lett. 325: 161-166.
51. Thirstrup K, Elling CE, Hjorth SA, Schwartz TW. 1996. Construction of a high affinity zinc switch in the kappa-opioid receptor. J. Biol. Chem. 271: 7875-7878.
52. van Regenmortel MH. 2006. Immunoinformatics may lead to a reappraisal of the nature of B cell epitopes and of the feasibility of synthetic peptide vaccines. J. Mol. Recognit. 19: 183-187.
53. von Euler U, Gaddum J. 1931. An unidentified depressor substance in certain tissue extracts. J. Physiol. (Lond.) 72: 74-87.
54. Werge TM. 1994. Identification of an epitope in the substance P receptor important for recognition of the common carboxyl-terminal tachykinin sequence. J. Biol. Chem. 269: 22054-22058.